glp 1 complications Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds GLP-1 side effects: Normal or

Early research is reassuring

Oral GLP-1 therapies are viewed as a major future growth segment because they can improve access and reduce injection-related barriers

In recent years, the FDA has begun approving GLP-1s specifically for chronic weight management to help treat obesity, as they can increase satiety, decrease hunger and result in significant weight loss

Furthermore, there was a significant reduction of CRP level with semaglutide ( 43.5% vs 7.3% with placebo, estimated treatment ratio, 0.61

Guirguis says combination treatments such as this could offer additive or synergistic effects meaning that patients have a better chance of responding to at least one of the mechanisms and could experience fewer GI side effects as a result of the dual approach